Page results
-
Concerned about the impact of climate change on people with neurological conditions, Professor Sanjay Sisodiya has established established a consortium of neurological specialists and will be undertaking research.
-
An ambitious project has helped make the University College Hospital Outpatients Department much more pleasant and easy to navigate.
-
This page explains how PIFU will work for you once you have finished your treatment for lymphoma.
-
This leaflet explains what strong opioid patches are, and how they are used for pain relief at UCLH.
-
This page explains more about the Prostate One-Day Clinic and what you can expect when you come for your appointment. If you have any questions about your appointment or the information included on this page, please contact one of our prostate clinical nurse specialists (CNSs).
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
Information on parvovirus for patients with haemolytic anaemias.
-
This page provides information about different medicines that might help to relieve neuropathic pain.
-
Information about medications, vaccinations and travel for people with sickle cell disorder.
-
Information about the use of deferasirox iron chelation treatment for iron overload.
File results
-
FOI/2022/0717 - Digital Healthcare organisation chart
-
FOI/2022/0718 - Clinical service incidents caused by estates and infrastructure in 2021/22
-
FOI/2022/0722 - Procedures for patients on lateral flow tests and wearing masks in hospital
-
FOI/2022/0723 - Spend on external companies for intraoperative neuromonitoring (IONM)
-
FOI/2022/0724 - Radiology enquiry - brain imaging, prostate, breast, Liver, Gynaecological scans within MRI
-
FOI/2022/0725 - High Acuity Monitoring - NCIU, Theatres, ICU
-
FOI/2022/0728 - Digital/ data team structures
-
FOI/2022/0730 - Outpatient unit day procedures for haematology patients
-
FOI/2022/0734 - A&E attendances for episodes of sunburn and/ or effects of heat and light
-
FOI/2022/0739 - Treatment of HR+ adjuvant breast cancer